5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Dr. Reddy's Laboratories Ltd.

•
drreddys.comBSE: 500124NSE: DRREDDY
Market Cap₹ 95,421 Cr.
Current Price
High / Low₹ 1,415 / 1,101
Stock P/E143.9
Book Value₹ 379
Price to Book3.36
Dividend Yield0.70 %
ROCE12.7 %
ROE10.7 %
Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2024 • Global Generics: 88.9% • Pharmaceutical Services & Active Ingredients: 10.3% • Other Operating Revenue: 0.4%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has a healthy return on capital (ROCE) of 21.3%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.96x)
  • Company comfortably covers its interest (29.7x coverage)
  • Company has a consistent dividend-paying track record
  • Company maintains a comfortable, low leverage position

CONS

  • Recent results are weak - TTM profit is down 92.4% versus prior year
  • A large part of profit comes from other income (39.7% of PBT)
  • Valuation is stretched - P/E of 143.9 is well above its own 5-year median (11.9)
  • Total debt has risen sharply - up 64.2% year on year
  • Operating margins have contracted to 19.1% from 24.8%
  • Company has delivered a poor profit growth of 8.0% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY100 EQL WGTNIFTY50 EQL WGTNIFTY PHARMANIFTY100 QUALTY30
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.10362.07123.942026.3129.1018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.BIOCON395.00129.9764372.920.13136.8053.364336.0010.893.2619.54
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
5,4204,8044,0395,0825,8245,8534,7785,5467,7894,5594,0723,8035,137
3,2103,2103,4473,7263,8883,9753,8234,1203,9724,1384,1834,3225,080
Operating Profit2,2111,5945921,3561,9361,8799551,4263,816420-111-51957
OPM %40.78%33.18%14.66%26.68%33.24%32.10%19.99%25.72%49.00%9.22%-2.73%-13.66%1.10%
234223228213218208235414398364360567440
Interest466672843311933415473
Depreciation237246246246250260265264280295314318318
Profit before Tax2,2201,6016321,3391,9142,6411,1191,5623,936516104-306497
Tax %26.14%25.49%24.80%22.73%25.95%28.73%24.12%23.12%24.77%24.99%13.05%28.18%18.57%
Net Profit1,6391,1934751,0351,4171,8828491,2012,96138791-219405
98.6671.495.7112.4317.0222.6010.2014.4135.594.651.09-2.634.86

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
9,7209,35910,62611,85013,34914,40516,96219,48423,11520,53317,570
8,0418,0878,3618,98110,21211,81112,74813,55715,73416,61517,723
Operating Profit1,6791,2732,2652,8703,1372,5944,2155,9267,3823,917-154
OPM %17.27%13.60%21.31%24.22%23.50%18.01%24.85%30.42%31.93%19.08%-0.87%
6582612747438014825918621,0031,6901,732
Interest5763574847381722110148202
Depreciation7357747817898358149239761,0391,2071,245
Profit before Tax1,5446971,7012,7763,0562,2243,8665,7917,2364,251812
Tax %10.39%18.67%24.90%-5.83%28.46%27.01%32.42%25.03%26.07%24.27%18.33%
Net Profit1,3845671,2772,9382,1861,6232,6134,3425,3493,220663
EPS82.8834.1276.85176.88131.4697.58157.03260.3164.1438.56—
Dividend Payout %23.96%58.56%25.99%14.14%19.03%30.75%25.51%15.37%12.47%20.75%—

COMPOUNDED SALES GROWTH

10 Years:
7%
5 Years:
9%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
9%
5 Years:
8%
3 Years:
7%

STOCK PRICE CAGR

10 Years:
6%
5 Years:
3%
3 Years:
1%
1 Year:
-12%

RETURN ON EQUITY

10 Years:
14%
5 Years:
15%
3 Years:
17%
Last Year:
11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jul 10

₹ 8

Rs.8.0000 per share(800%)Final Dividend

2025

Jul 10

₹ 8

Rs.8.0000 per share(800%)Final Dividend

2024

Jul 16

₹ 8

Rs.40.0000 per share(800%)Final Dividend

2023

Jul 11

₹ 8

Rs.40.0000 per share(800%)Final Dividend

2022

Jul 11

₹ 6

Rs.30.0000 per share(600%)Final Dividend

2021

Jul 9

₹ 5

Rs.25.0000 per share(500%)Final Dividend

2020

Jul 13

₹ 5

Rs.25.0000 per share(500%)Final Dividend

2018

Jul 16

₹ 4

Rs.20.0000 per share(400%)Final Dividend

2017

Jul 17

₹ 4

Rs.20.0000 per share(400%)Dividend

2016

Jul 18

₹ 4

Rs.20.0000 per share(400%)Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital83838383838383838384
11,43711,64212,52215,00516,77418,11020,24524,02628,62831,133
2,3962,6209201,1081,2412,2751148983,6785,979
Trade Payables7791,0611,0321,0681,3361,6661,7642,0451,9931,904
1,6701,6011,6911,5981,9402,3423,1673,3073,9084,502
Total Liabilities16,36517,00716,24818,86321,37524,47625,37530,35938,29143,602
4,8424,7174,6834,4345,8446,1507,1957,5898,23210,730
Capital Work in Progress5406754003848771,1868991,1722,1561,369
3,1023,6363,9345,4864,6494,9377,4407,32113,19415,595
1,8101,8572,0162,1902,8203,3483,0434,0194,5764,956
14714824242627214,6245,9594,119
Cash & Bank67121113391,6462,0306461,2179771,958
5,8585,8535,0786,3065,5126,7976,1314,4183,1974,876
Total Assets16,36517,00716,24818,86321,37524,47625,37530,35938,29143,602

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
1,3391,7133,0012,3163,9621,8285,8363,4504,2254,660
Cash from Investing1,442-1,180-551-1,689-1,458-2,038-3,448-3,430-5,698-5,785
Cash from Financing-2,582-304-2,223-224-794506-2,697681,5911,117
-12354-12-741,262-194-1,09288118-7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
26.6526.6426.6426.6426.6426.6426.6426.6326.64
27.6827.5326.8525.7525.3324.6922.3421.1420.66
20.7221.4822.8925.6326.7327.9930.4430.7231.75
Government0.000.000.000.000.000.000.000.000.00
10.3610.1310.3810.4410.269.869.719.579.55

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10
General Updates

2026-09-10 - Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of Employee Stock options

2026-09-10
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-10 - Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet

2026-08-26
General Updates

2026-08-26 - Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of employee stock options

2026-08-20
Copy of Newspaper Publication

2026-08-20 - Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-14
General Updates

2026-08-14 - Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates

2026-08-14
General Updates

2026-08-14 - Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates

2026-08-13
Resignation of Director/KMP/SMP

2026-08-13 - Dr. Reddy's Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-13
Change in Management

2026-08-13 - Dr. Reddy's Laboratories Limited has informed the Exchange about change in Management

2026-08-07
General Updates

2026-08-07 - Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates

News

Recent coverage and analyst commentary for DRREDDY

Loading news…

🤖

AI Stock Analyst

Dr. Reddy's Laboratories Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login